Lu; Wei-Shu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lu; Wei-Shu.The latest application filed is for "diacerein or rhein topical formulations and uses thereof".

Company Profile

4.11.14

Lu; Wei-Shu - New Taipei TW
Lu; Wei-Shu - Taipei TW
Lu; Wei-Shu - New Taipei City TW
Lu; Wei-Shu - Tucheng TW
Lu; Wei-Shu - Tucheng City TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and pharmaceutical compositions for preventing or treating immunoinflammatory dermal disorders Grant 10,675,260 - Tseng , et al.	2020-06-09
Diacerein or rhein topical formulations and uses thereof Grant 10,512,625 - Chen , et al. Dec	2019-12-24
Diacerein Or Rhein Topical Formulations And Uses Thereof App 20190105296 - Chen; Chih-Kuang ; et al.	2019-04-11
Methods for inhibiting expression of ASC, expression of NLRP3, and/or formation of NLRP3 inflammasome complex using diacerein or its analogs Grant 10,195,170 - Chen , et al. Fe	2019-02-05
Diacerein or Rhein topical formulations and uses thereof Grant 10,154,984 - Chen , et al. Dec	2018-12-18
Methods And Pharmaceutical Compositions For Preventing Or Treating Immunoinflammatory Dermal Disorders App 20180200235 - Tseng; Po-Yuan ; et al.	2018-07-19
Diacerein Or Rhein Topical Formulations And Uses Thereof App 20180021290 - Chen; Chih-Kuang ; et al.	2018-01-25
Methods And Formulations For Treatment And/or Prevention Of Blood-associated Disorders App 20170319532 - Chen; Chih-Kuang ; et al.	2017-11-09
Diacerein or rhein topical formulations and uses thereof Grant 9,744,131 - Chen , et al. August 29, 2	2017-08-29
Methods For Inhibiting Expression Of Asc, Expression Of Nlrp3, And/or Formation Of Nlrp3 Inflammasome Complex Using Diacerein Or Its Analogs App 20170049733 - Chen; Chih-Kuang ; et al.	2017-02-23
Diacerein Or Rhein Topical Formulations And Uses Thereof App 20170000732 - Chen; Chih-Kuang ; et al.	2017-01-05
Formulations Containing Diacerein And Methods Of Lowering Blood Levels Of Uric Acid Using The Same App 20160303050 - Lim; Hanpin ; et al.	2016-10-20
Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia Grant 8,865,689 - Ku , et al. October 21, 2	2014-10-21
Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia Grant 8,846,758 - Ku , et al. September 30, 2	2014-09-30
Methods of using diacerein as an adjunctive therapy for diabetes Grant 8,536,152 - Ku , et al. September 17, 2	2013-09-17
Pharmaceutical Compositions Containing Diacerein App 20130156857 - Gao; Danchen ; et al.	2013-06-20
Methods Of Decreasing Glycosylated Hemoglobin In Patients With Dyslipidemia App 20130022610 - Ku; Mannching Sherry ; et al.	2013-01-24
Methods And Compositions For Treating Hyperuricemia And Metabolic Disorders Associated With Hyperuricemia App 20120232044 - Ku; Mannching Sherry ; et al.	2012-09-13
Methods of Using Diacerein as an Adjunctive Therapy for Diabetes App 20110251155 - Ku; Mannching Sherry ; et al.	2011-10-13
Methods For Diagnosing Diabetes And Determining Effectiveness Of Treatments App 20110045522 - Gao; Danchen ; et al.	2011-02-24
Pharmaceutical Compositions Containing Diacerein App 20100104651 - Gao; Danchen ; et al.	2010-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.